Literature DB >> 1420300

Essential fatty acid metabolism in cultured human airway epithelial cells.

J X Kang1, S F Man, N E Brown, P A Labrecque, M L Garg, M T Clandinin.   

Abstract

To characterize essential fatty acid metabolism of human airway epithelium, we examined the capacity of epithelial cells to incorporate and desaturate/elongate 18:2(n - 6) and the turnover of phospholipid fatty acyl chains in these cells. Epithelial cells were cultured for 5-7 days and incubated with [1-14C]18:2(n - 6) (1 microCi, 100 nmol). The essential fatty acid profile of the cells was readily modified by 18:2(n - 6) supplementation to culture medium. After 4 h incubation, 32 +/- 5.6 nmol of [1-14C]18:2(n - 6) was incorporated into phospholipids (65 +/- 9.5%, of which 74% was incorporated into phosphatidylcholine (PC)) and neutral lipid (31 +/- 10%) per mg protein of cultured cells. 30 +/- 8% of [1-14C]18:2(n - 6) incorporated, was converted to homologous trienes, tetraenes and pentaenes, the major products being 20:3(n - 6) and 20:4(n - 6). The conversion of 18:2(n - 6) was time-dependent and donor age-related. A higher proportion of 20:3(n - 6) and 20:4(n - 6) was incorporated into phosphatidylinositol (PI) and phosphatidylethanolamine (PE). About 10-15% of total products formed from 18:2(n - 6) was released from membrane to culture medium. Both 20:4(n - 6) and 20:5(n - 3) inhibited 18:2(n - 6) incorporation and desaturation. Rate of incorporation of 18:2(n - 6) was more than either 18:1(n - 9) or 16:0. With pulse-chase studies, the half-life of 18:2(n - 6) in PC, PI and PE was estimated to be 5.5, 6.0 and 7.3 h, respectively. These data indicate active metabolism of essential fatty acids in human airway epithelial cells. This metabolism may play a key role in the regulation of membrane properties and function in these cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420300     DOI: 10.1016/0005-2760(92)90317-o

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Adenoviral gene transfer of Caenorhabditis elegans n--3 fatty acid desaturase optimizes fatty acid composition in mammalian cells.

Authors:  Z B Kang; Y Ge; Z Chen; J Cluette-Brown; M Laposata; A Leaf; J X Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

2.  Effect of dietary docosahexaenoic acid on biosynthesis of docosahexaenoic acid from alpha-linolenic acid in young rats.

Authors:  James C DeMar; Carmine DiMartino; Adam W Baca; William Lefkowitz; Norman Salem
Journal:  J Lipid Res       Date:  2008-05-09       Impact factor: 5.922

3.  A modified n-3 fatty acid desaturase gene from Caenorhabditis briggsae produced high proportion of DHA and DPA in transgenic mice.

Authors:  Guiming Zhu; Hongxing Chen; Xiaojie Wu; Yanrong Zhou; Jianshen Lu; Hong Chen; Jixian Deng
Journal:  Transgenic Res       Date:  2008-03-06       Impact factor: 2.788

4.  Characterization of platelet-activating factor binding to human airway epithelial cells: modulation by fatty acids and ion-channel blockers.

Authors:  J X Kang; S F Man; A J Hirsh; M T Clandinin
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

5.  A simplified method for analysis of polyunsaturated fatty acids.

Authors:  Jing X Kang; Jingdong Wang
Journal:  BMC Biochem       Date:  2005-03-24       Impact factor: 4.059

6.  Sensitivity of Osteosarcoma Cells to Concentration-Dependent Bioactivities of Lipid Peroxidation Product 4-Hydroxynonenal Depend on Their Level of Differentiation.

Authors:  Suzana Borovic Sunjic; Ana Cipak Gasparovic; Morana Jaganjac; Gerald Rechberger; Andreas Meinitzer; Tilman Grune; Sepp D Kohlwein; Branka Mihaljevic; Neven Zarkovic
Journal:  Cells       Date:  2021-01-29       Impact factor: 6.600

7.  Gene transfer of Chlorella vulgaris n-3 fatty acid desaturase optimizes the fatty acid composition of human breast cancer cells.

Authors:  Meilan Xue; Yinlin Ge; Jinyu Zhang; Qing Wang; Lin Hou
Journal:  Braz J Med Biol Res       Date:  2012-09-11       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.